Immage Biotherapeutics Corp.
IMMG · OTC
2/28/2017 | 11/30/2016 | 8/31/2016 | 5/31/2016 | |
|---|---|---|---|---|
| Market Cap | $0 | $0 | $0 | $0 |
| - Cash | $54 | $127 | $197 | $265 |
| + Debt | $0 | $0 | $53 | $0 |
| Enterprise Value | -$54 | -$127 | -$144 | -$265 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | – | – | – | – |
| EBITDA | -$42 | -$1,669 | -$60 | -$49 |
| % Margin | – | – | – | – |
| Net Income | -$0 | -$2 | -$62 | -$51 |
| % Margin | – | – | – | – |
| EPS Diluted | -0 | -0.011 | -0 | -0 |
| % Growth | 97.3% | -2,700% | -33.3% | – |
| Operating Cash Flow | -$72 | -$71 | -$69 | -$62 |
| Capital Expenditures | $0 | $0 | $0 | $0 |
| Free Cash Flow | -$72 | -$71 | -$69 | -$62 |